Drug intelligence / Profile preview

thuja orientalis

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Thuja orientalis is an evergreen coniferous tree in the cypress family (Cupressaceae), used in traditional East Asian medicine. Extracts from the leaves, twigs, and seeds are used for a variety of indications, such as treating gout, rheumatism, diarrhea, chronic tracheitis, and hair loss. In preclinical studies, its extracts have demonstrated anti-inflammatory, immunomodulatory, and possible hair-growth-promoting effects. Mechanistically, Thuja orientalis may exert its effects by reducing Th2 cytokines (IL-4, IL-5, and IL-13) and eotaxin, inhibiting expression of inducible nitric oxide synthase (iNOS) and matrix metalloproteinase-9 (MMP-9) in inflammatory models, and acting as a 5α-reductase inhibitor, which might be relevant in androgenetic alopecia. The plant contains bioactive compounds including flavonoids and diterpenes. No large, high-quality clinical trials for single-ingredient Thuja orientalis products have been published.

Other names
thujaoriental arborvitaeplatycladus orientalisChinese cedarbiota
02

Targets

SRD5A2 (Steroid 5-alpha-reductase type II)CCL11 (C-C motif chemokine ligand 11)NOS2 (Nitric Oxide Synthase 2)MMP9 (Matrix metalloproteinase-9)SRD5A (Steroid 5-alpha-reductase)

Beyond the preview

Go deeper on thuja orientalis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thuja orientalis.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call